Serialization resets and supply‑chain sync

Drugmakers and regulators are reopening the rules for tracking medicines, just as software vendors push to tie those records to day-to-day supply decisions. (pharmaceuticalcommerce.com) (tracelink.com) Serialization means giving each saleable drug pack its own identifier, usually in a two-dimensional barcode, so trading partners can verify and trace it through the supply chain. The United States Drug Supply Chain Security Act calls for an interoperable electronic system to trace certain prescription drugs at the package level. (fda.gov) (health.ec.europa.eu) In the United States, the Food and Drug Administration gave trading partners a stabilization period from November 2023 to November 27, 2024, to build and test electronic, interoperable tracing systems. The agency also granted certain small dispensers exemptions that run until November 27, 2026. (fda.gov 1) (fda.gov 2) In Europe, the Falsified Medicines Directive and Commission Delegated Regulation (European Union) 2016/161 require safety features, verification rules, and a repositories system for many human medicines. The European Commission says that system has applied since February 9, 2019. (health.ec.europa.eu) (eur-lex.europa.eu) Pharmaceutical Commerce reported in March that industry activity had slowed but not stopped, with companies still moving ahead for markets including Turkey and parts of Europe. The same coverage said Washington and Brussels were revisiting how serialization programs should work after uneven implementation and shifting deadlines. (pharmaceuticalcommerce.com) That policy reset is landing alongside a new commercial push from TraceLink and Kinaxis. On April 15, 2026, the companies said they expanded their partnership to connect Kinaxis Maestro planning software with live trading-partner data from the TraceLink network. (tracelink.com) (tmcnet.com) Kinaxis describes concurrent planning as a way to update the whole supply chain in near real time when one part changes, instead of passing revisions step by step between functions. TraceLink said the joint product is meant to feed that planning loop with execution data from manufacturers, wholesalers, and other partners. (kinaxis.com) (tracelink.com) The gap between traceability and security is still unresolved. Pharmaceutical Commerce reported on March 24 that a serialized barcode can still be copied onto counterfeit packaging, meaning compliance systems can improve visibility without fully stopping fraud. (pharmaceuticalcommerce.com) So the current debate is moving on two tracks at once: regulators are still working through what compliant traceability should look like in practice, and software companies are selling tools that treat those records as live operating data. The next test is whether the rules and the software finally line up across pharmacies, wholesalers, manufacturers, and national verification systems. (fda.gov) (health.ec.europa.eu)